|Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections|
J Li, RL Nation, JD Turnidge, RW Milne, K Coulthard, CR Rayner, ...
The Lancet infectious diseases 6 (9), 589-601, 2006
|Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review|
AP Zavascki, LZ Goldani, J Li, RL Nation
Journal of antimicrobial chemotherapy 60 (6), 1206-1215, 2007
|Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production|
JH Moffatt, M Harper, P Harrison, JDF Hale, E Vinogradov, T Seemann, ...
Antimicrobial agents and chemotherapy 54 (12), 4971-4977, 2010
|Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various …|
SM Garonzik, J Li, V Thamlikitkul, DL Paterson, S Shoham, J Jacob, ...
Antimicrobial agents and chemotherapy 55 (7), 3284-3294, 2011
|Structure− activity relationships of polymyxin antibiotics|
T Velkov, PE Thompson, RL Nation, J Li
Journal of medicinal chemistry 53 (5), 1898-1916, 2010
|Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria|
J Li, RL Nation, RW Milne, JD Turnidge, K Coulthard
International journal of antimicrobial agents 25 (1), 11-25, 2005
|Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii|
J Li, CR Rayner, RL Nation, RJ Owen, D Spelman, KE Tan, L Liolios
Antimicrobial agents and chemotherapy 50 (9), 2946-2950, 2006
|International consensus guidelines for the optimal use of the polymyxins: endorsed by the American college of clinical pharmacy (ACCP), European society of clinical …|
BT Tsuji, JM Pogue, AP Zavascki, M Paul, GL Daikos, A Forrest, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (1 …, 2019
|Pharmacology of polymyxins: new insights into an ‘old’class of antibiotics|
T Velkov, KD Roberts, RL Nation, PE Thompson, J Li
Future microbiology 8 (6), 711-724, 2013
|Colistin in the 21st century|
RL Nation, J Li
Current opinion in infectious diseases 22 (6), 535, 2009
|Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa|
PJ Bergen, J Li, CR Rayner, RL Nation
Antimicrobial agents and chemotherapy 50 (6), 1953-1958, 2006
|Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens|
AM Sandri, CB Landersdorfer, J Jacob, MM Boniatti, MG Dalarosa, ...
Clinical infectious diseases 57 (4), 524-531, 2013
|Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus|
RL Nation, J Li, O Cars, W Couet, MN Dudley, KS Kaye, JW Mouton, ...
The Lancet infectious diseases 15 (2), 225-234, 2015
|Kucers' The Use of Antibiotics Sixth Edition: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs|
ML Grayson, SM Crowe, JS McCarthy, J Mills, JW Mouton, SR Norrby, ...
CRC Press, 2010
|Colistin and polymyxin B: peas in a pod, or chalk and cheese?|
RL Nation, T Velkov, J Li
Clinical infectious diseases 59 (1), 88-94, 2014
|In Vitro Pharmacodynamic Properties of Colistin and Colistin Methanesulfonate against Pseudomonas aeruginosaIsolates from Patients with Cystic Fibrosis|
J Li, J Turnidge, R Milne, RL Nation, K Coulthard
Antimicrobial agents and chemotherapy 45 (3), 781-785, 2001
|iLearn: an integrated platform and meta-learner for feature engineering, machine-learning analysis and modeling of DNA, RNA and protein sequence data|
Z Chen, P Zhao, F Li, TT Marquez-Lago, A Leier, J Revote, Y Zhu, ...
Briefings in bioinformatics 21 (3), 1047-1057, 2020
|Management of meningitis due to antibiotic-resistant Acinetobacter species|
BN Kim, AY Peleg, TP Lodise, J Lipman, J Li, R Nation, DL Paterson
The Lancet infectious diseases 9 (4), 245-255, 2009
|Dosing guidance for intravenous colistin in critically ill patients|
RL Nation, SM Garonzik, V Thamlikitkul, EJ Giamarellos-Bourboulis, ...
Clinical Infectious Diseases 64 (5), 565-571, 2017
|Pharmacokinetics of intravenous polymyxin B in critically ill patients|
AP Zavascki, LZ Goldani, G Cao, SV Superti, L Lutz, AL Barth, F Ramos, ...
Clinical infectious diseases 47 (10), 1298-1304, 2008